Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. N Engl J Med. 2014 Jul 17; 371(3):213-23.
View in:
PubMed
subject areas
Adenine
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Cough
Diarrhea
Disease-Free Survival
Fatigue
Female
Follow-Up Studies
Humans
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Middle Aged
Piperidines
Protein-Tyrosine Kinases
Pyrazoles
Pyrimidines
Recurrence
Survival Rate
authors with profiles
Jennifer Ruth Brown, Ph.D., M.D.